InsiderTrades

Form 4 for BSX Boston Scientific

Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-15 · accession 0001225208-23-002151 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-16 2023-02-15 BSX Carruthers Wendy EVP, Human Resources F - Tax $47.29 -737 89.6K -0.8% -$34.9K
D 2023-02-16 2023-02-15 BSX Carruthers Wendy EVP, Human Resources M - OptEx $0.00 +1,661 90.3K +2% $0
D 2023-02-16 2023-02-15 BSX Carruthers Wendy EVP, Human Resources M - OptEx $0.00 -1,661 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-15 F D 737 $47.29 89,609 D — —
2 Common Common Stock 2023-02-15 M A 1,661 $0.00 90,346 D — — (F1) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
3 Derivative Deferred Stock Units 2023-02-15 M D 1,661 $0.00 0 D — · — to 2023-02-15 1,661 Common Stock (F1) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F2) Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.